Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Melodiol Global Health (AU:ME1)
ASX:ME1
Melodiol Global Health (ME1) Share Price & Analysis
14 Followers
ME1 Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$7.20
Previous CloseAU$0.01
Volume29.98M
Average Volume (3M)4.02M
Market Cap
AU$245.96K
Enterprise ValueAU$5.39M
Total Cash (Recent Filing)AU$1.39M
Total Debt (Recent Filing)AU$6.67M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.29
Shares Outstanding117,774,975
10 Day Avg. Volume2,448,703
30 Day Avg. Volume4,022,573
Standard Deviation0.34
R-Squared0.09
Alpha-0.00959
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Melodiol Global Health News
PremiumCompany Announcements
Melodiol Issues New Shares, Affirms Transparency
PremiumCompany Announcements
Melodiol Issues New Shares, Meets Regulations
PremiumCompany Announcements
Melodiol Global Health Eyes ASX Listing
PremiumCompany Announcements
Melodiol Global Health Expands ASX Quoted Shares
PremiumCompany Announcements
Melodiol Applies for Major ASX QuotationPremiumCompany Announcements
Melodiol Corrects Share Issuance Figure
PremiumCompany Announcements
Melodiol Applies for New Securities Quotation
PremiumCompany Announcements
Melodiol Issues Shares, Affirms TransparencyME1 FAQ
What was Melodiol Global Health’s price range in the past 12 months?
Melodiol Global Health lowest share price was <AU$0.01 and its highest was AU$7.20 in the past 12 months.
What is Melodiol Global Health’s market cap?
Currently, no data Available
When is Melodiol Global Health’s upcoming earnings report date?
Melodiol Global Health’s upcoming earnings report date is Aug 28, 2024 which is in 36 days.
How were Melodiol Global Health’s earnings last quarter?
Melodiol Global Health released its earnings results on Feb 29, 2024. The company reported -AU$3.51 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$3.51.
Is Melodiol Global Health overvalued?
According to Wall Street analysts Melodiol Global Health’s price is currently Overvalued.
Does Melodiol Global Health pay dividends?
Melodiol Global Health does not currently pay dividends.
What is Melodiol Global Health’s EPS estimate?
Melodiol Global Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Melodiol Global Health have?
Melodiol Global Health has 36,438,076 shares outstanding.
What happened to Melodiol Global Health’s price movement after its last earnings report?
Melodiol Global Health reported an EPS of -AU$3.51 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Melodiol Global Health?
Currently, no hedge funds are holding shares in AU:ME1
---
Melodiol Global Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:ME1 Sentiment 60%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-385.89%
Trailing 12-Months
Asset Growth
-49.55%
Trailing 12-Months
Company Description
Melodiol Global Health
Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel and Australia. The company derives prime revenue from the Europe and Middle East regions.
---
Melodiol Global Health
―
Zynex
―
ACADIA Pharmaceuticals
―
Innoviva
―
Merck & Company
―
---